Description
Composition (Each Film-Coated Tablet Contains):
-
MV1Forte: Glimepiride 1 mg + Metformin Hydrochloride 500 mg + Voglibose I.P. 0.3 mg
-
MV2Forte: Glimepiride 2 mg + Metformin Hydrochloride 500 mg + Voglibose I.P. 0.3 mg
Category: Diabetes Care / Triple Oral Antidiabetic Therapy
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu or Blister Pack
Product Description:
SUGATAB® – MV1Forte / MV2Forte is a triple fixed-dose combination specially developed for patients with type 2 diabetes mellitus (T2DM) who are not achieving glycemic control with dual therapy. It combines the insulin secretagogue action of Glimepiride, the insulin-sensitizing effect of Metformin, and the postprandial glucose-lowering action of Voglibose 0.3mg — a higher-strength alpha-glucosidase inhibitor for enhanced control of sugar spikes after meals.
Key Benefits:
-
Triple-mechanism therapy for comprehensive glycemic control
-
Stronger postprandial glucose management with Voglibose 0.3mg
-
Controls fasting and post-meal blood sugar effectively
-
Helps reduce HbA1c with low risk of long-term complications
-
Suitable for patients with uncontrolled or progressive T2DM
How it works:
-
Glimepiride stimulates insulin release from pancreatic beta cells in a glucose-dependent manner
-
Metformin reduces hepatic glucose production and enhances peripheral glucose uptake
-
Voglibose delays carbohydrate absorption in the intestine, reducing post-meal sugar spikes
Together, these agents provide multi-targeted control of blood glucose, improving both metabolic stability and quality of life in T2DM patients.
How to use:
-
Take one tablet twice daily, before the two largest meals of the day, or as advised by your physician
-
Swallow whole with water — do not split or chew
-
Avoid skipping meals after dosing
-
Monitor blood sugar levels regularly for optimal control
Safety Advice:
-
Mild bloating or flatulence may occur initially due to Voglibose
-
Risk of hypoglycemia increases if meals are skipped — always take with food
-
Avoid alcohol and monitor kidney and liver function during treatment
-
Adhere to dietary recommendations and hydration guidelines
Precautions:
-
Not recommended for type 1 diabetes or diabetic ketoacidosis (DKA)
-
Use with caution in patients with renal or hepatic impairment, gastrointestinal disorders, or elderly patients
-
Not advised during pregnancy or breastfeeding unless prescribed by a physician
-
Inform your doctor about any other antidiabetic medications, insulin, or supplements in use
Storage:
Store in a cool, dry place below 25°C.
Protect from direct sunlight and moisture.
Keep out of reach of children.
Reviews
There are no reviews yet.